Noki Labs Editorial Team & Review Process
Every page on Noki Labs is reviewed by our internal Editorial Team before publishing. We take peptide-research transparency seriously — here's what that means in practice.
Who reviews our content
The Noki Labs Editorial Team is composed of in-house writers, peptide-research analysts, and licensed pharmacist consultants who validate every published page against current peer-reviewed literature, FDA-PH guidance, and third-party Certificate of Analysis data.
We do not publish anonymous medical claims. Every dosing protocol, side-effect note, and mechanism explanation cites or links to the underlying source.
Our 5-stage review process
- Source verification. Every claim in a draft must trace to a peer-reviewed paper (PubMed/Lancet/NEJM), an official manufacturer document, or a third-party CoA. No "common knowledge" sourcing.
- Peptide-research analyst review. Our analyst pass checks for mechanism accuracy, dosing math (mg ⇄ IU ⇄ syringe units), and stability/storage claims.
- Compliance review. A pharmacist consultant reviews wording for FDA-PH alignment — we do not make therapeutic claims, only educational claims about peptide research.
- Editorial polish. Plain-English pass for Filipino consumers — acronyms defined, units consistent, claims tempered to what the literature actually shows.
- Last-reviewed stamp. Every page carries a "Last reviewed: [Month Year]" stamp. We re-review when new clinical evidence emerges.
Sourcing transparency
We publish:
- Manufacturing origin for every batch we ship.
- Batch numbers stamped on every vial, with matching CoA available on request via support@nokilabs.com.
- Storage handling logs from our Metro Manila cold-chain facility — every shipment tracked from receipt to dispatch.
- Sample CoA library at /pages/lab-testing showing 10 representative batches with full assay panels.
Conflict-of-interest policy
Noki Labs is a Philippine peptide supplier. We sell the products we write about. To keep our editorial separate from our commercial interest:
- We never claim therapeutic outcomes our underlying products are not designed to deliver — e.g. we do not market peptides as cures, treatments, or weight-loss guarantees.
- We publish negative findings. Where research shows a peptide has limited evidence (e.g. AOD-9604 in oral form, certain antiwrinkle peptides), we say so plainly.
- We compare honestly. Our "vs" comparison pages name the situations where competitors' products fit better, when applicable.
- We do not pay for influencer endorsements or accept commission-based reviews.
How to reach editorial
Spotted an inaccuracy? Want a citation we missed? Want a peptide reviewed?
Email support@nokilabs.com with subject line "Editorial: [topic]" and we will respond within 2 business days.
Our standards in one paragraph
We treat peptide research the way we want our own healthcare to be treated: with citations, with transparency, with a willingness to say "the evidence is mixed" or "we don't know yet." We are a commercial supplier, but we will not sell you on a peptide that the literature does not support. Every page on this site is reviewed against that standard before it goes live.
The Noki Labs Editorial Team · Last updated: May 2026
Always consult a licensed healthcare provider before starting any new peptide or wellness regimen. Individual results vary. Statements about our products are educational and not intended to diagnose, treat, cure, or prevent any disease.